Premium
Sophia Genetics SA (SOPH)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-12 | Dr. Philippe MenuExec. VP, Chief Medical Officer & Chief Product Officer | -5,00k | 24,75k | Automatic Disposition | 4,95 | 245,78k | -1,99% |
| 2026-06-10 | Dr. Jurgi CamblongCo-Founder, CEO & Director | -8,50k | 44,50k | Automatic Disposition | 5,24 | 3,62M | -0,23% |
| 2026-06-05 | Mr. George A. CardozaExec. VP & CFO | 20,00k | 99,00k | Achat | 4,95 | 311,46k | 6,86% |
| 2026-05-26 | Dr. Philippe MenuExec. VP, Chief Medical Officer & Chief Product Officer | -5,00k | 24,77k | Automatic Disposition | 4,95 | 250,78k | -1,95% |
| 2026-05-19 | Mr. Ross Jordan MukenPresident | -761,00 | 3,50k | Automatic Disposition | 4,60 | 680,91k | -0,11% |
| 2026-05-19 | Dr. Zhenyu XuExec. VP & Chief Scientific Officer | -608,00 | 2,80k | Automatic Disposition | 4,60 | 626,28k | -0,10% |
| 2026-05-19 | Dr. Jurgi CamblongCo-Founder, CEO & Director | -4,49k | 20,66k | Automatic Disposition | 4,60 | 3,63M | -0,12% |
| 2026-05-19 | Dr. Philippe MenuExec. VP, Chief Medical Officer & Chief Product Officer | -608,00 | 2,80k | Automatic Disposition | 4,61 | 255,78k | -0,24% |
| 2026-05-19 | Mr. Daan van WellExec. VP and Chief Legal & Compliance Officer | -684,00 | 3,15k | Automatic Disposition | 4,60 | 345,05k | -0,20% |
| 2026-05-19 | Ms. Manuela Da Silva ValenteExec. VP & CPO | -380,00 | 1,75k | Automatic Disposition | 4,60 | 95,51k | -0,40% |
| 2026-05-19 | Mr. Kevin PuylaertSVP & Chief Sales Officer | -33,00 | 149,90 | Vente | 4,54 | 148,16k | -0,02% |
| 2026-05-13 | Dr. Zhenyu XuExec. VP & Chief Scientific Officer | -4,00k | 18,17k | Automatic Disposition | 4,54 | 626,89k | -0,63% |
| 2026-05-12 | Ms. Kathy L. HibbsIndependent Non-Executive Director | -7,51k | 35,04k | Automatic Disposition | 4,67 | 89,77k | -7,72% |
| 2026-05-12 | Dr. Philippe MenuExec. VP, Chief Medical Officer & Chief Product Officer | -5,00k | 23,34k | Automatic Disposition | 4,67 | 256,39k | -1,91% |
| 2026-05-11 | Dr. Jurgi CamblongCo-Founder, CEO & Director | -8,50k | 43,24k | Automatic Disposition | 5,09 | 3,63M | -0,23% |
| 2026-04-27 | Dr. Philippe MenuExec. VP, Chief Medical Officer & Chief Product Officer | -5,00k | 24,09k | Automatic Disposition | 4,82 | 261,39k | -1,88% |
| 2026-04-20 | Mr. Daan van WellExec. VP and Chief Legal & Compliance Officer | -684,00 | 3,55k | Automatic Disposition | 5,20 | 345,74k | -0,20% |
| 2026-04-20 | Dr. Zhenyu XuExec. VP & Chief Scientific Officer | -608,00 | 3,16k | Automatic Disposition | 5,21 | 630,89k | -0,10% |
| 2026-04-20 | Dr. Jurgi CamblongCo-Founder, CEO & Director | -4,49k | 23,35k | Automatic Disposition | 5,21 | 3,64M | -0,12% |
| 2026-04-20 | Ms. Manuela Da Silva ValenteExec. VP & CPO | -380,00 | 1,98k | Automatic Disposition | 5,20 | 95,89k | -0,39% |
| 2026-04-20 | Mr. Kevin PuylaertSVP & Chief Sales Officer | -33,00 | 167,69 | Vente | 5,08 | 148,20k | -0,02% |
| 2026-04-20 | Mr. Ross Jordan MukenPresident | -760,00 | 3,95k | Automatic Disposition | 5,20 | 681,67k | -0,11% |
| 2026-04-20 | Dr. Philippe MenuExec. VP, Chief Medical Officer & Chief Product Officer | -608,00 | 3,16k | Automatic Disposition | 5,20 | 266,39k | -0,23% |
| 2026-04-14 | Dr. Jurgi CamblongCo-Founder, CEO & Director | -60,60k | 301,24k | Automatic Disposition | 4,96 - 5,00 | 3,65M | -1,63% |
| 2026-04-14 | Dr. Zhenyu XuExec. VP & Chief Scientific Officer | -600,00 | 2,98k | Automatic Disposition | 4,97 | 631,50k | -0,09% |
| 2026-04-14 | Mr. Ross Jordan MukenPresident | -2,80k | 13,89k | Automatic Disposition | 4,96 | 682,43k | -0,41% |
| 2026-04-14 | Dr. Philippe MenuExec. VP, Chief Medical Officer & Chief Product Officer | -1,60k | 7,93k | Automatic Disposition | 4,96 | 267,00k | -0,60% |
| 2026-04-10 | Dr. Zhenyu XuExec. VP & Chief Scientific Officer | -8,12k | 38,37k | Automatic Disposition | 4,68 - 4,76 | 632,10k | -1,27% |
| 2026-04-10 | Mr. Daan van WellExec. VP and Chief Legal & Compliance Officer | -2,40k | 11,20k | Automatic Disposition | 4,67 | 346,42k | -0,69% |
| 2026-04-10 | Dr. Philippe MenuExec. VP, Chief Medical Officer & Chief Product Officer | -8,13k | 38,40k | Automatic Disposition | 4,68 - 4,76 | 268,60k | -2,94% |
| 2026-04-10 | Mr. Ross Jordan MukenPresident | -8,13k | 38,44k | Automatic Disposition | 4,69 - 4,77 | 685,23k | -1,17% |
| 2026-04-10 | Dr. Jurgi CamblongCo-Founder, CEO & Director | -16,63k | 78,67k | Automatic Disposition | 4,72 - 4,76 | 3,71M | -0,45% |
| 2026-04-08 | Dr. Philippe MenuExec. VP, Chief Medical Officer & Chief Product Officer | -4,73k | 22,70k | Automatic Disposition | 4,74 - 4,84 | 276,72k | -1,68% |
| 2026-04-08 | Dr. Zhenyu XuExec. VP & Chief Scientific Officer | -4,74k | 22,73k | Automatic Disposition | 4,74 - 4,84 | 640,22k | -0,73% |
| 2026-04-08 | Dr. Jurgi CamblongCo-Founder, CEO & Director | -4,75k | 22,80k | Automatic Disposition | 4,74 - 4,84 | 3,72M | -0,13% |
| 2026-04-08 | Mr. Ross Jordan MukenPresident | -4,74k | 22,73k | Automatic Disposition | 4,74 - 4,84 | 693,36k | -0,68% |
| 2026-04-08 | Mr. George A. CardozaExec. VP & CFO | -1,40k | 6,80k | Automatic Disposition | 4,85 | 291,46k | -0,48% |
| 2026-04-08 | Mr. Daan van WellExec. VP and Chief Legal & Compliance Officer | -4,85k | 23,29k | Automatic Disposition | 4,74 - 4,85 | 348,82k | -1,37% |
| 2026-04-08 | Ms. Manuela Da Silva ValenteExec. VP & CPO | -3,82k | 18,54k | Automatic Disposition | 4,85 | 95,70k | -3,84% |
| 2026-04-06 | Mr. Ross Jordan MukenPresident | -5,02k | 24,40k | Automatic Disposition | 4,85 - 4,87 | 698,10k | -0,71% |
| 2026-04-06 | Dr. Jurgi CamblongCo-Founder, CEO & Director | -5,10k | 24,77k | Automatic Disposition | 4,85 - 4,86 | 3,73M | -0,14% |
| 2026-04-06 | Mr. Daan van WellExec. VP and Chief Legal & Compliance Officer | -5,11k | 24,82k | Automatic Disposition | 4,86 - 4,87 | 353,67k | -1,42% |
| 2026-04-06 | Dr. Philippe MenuExec. VP, Chief Medical Officer & Chief Product Officer | -5,10k | 24,77k | Automatic Disposition | 4,85 - 4,87 | 281,45k | -1,78% |
| 2026-04-06 | Mr. Kevin PuylaertSVP & Chief Sales Officer | -624,00 | 3,03k | Vente | 4,83 - 4,86 | 148,23k | -0,42% |
| 2026-04-06 | Mr. George A. CardozaExec. VP & CFO | -4,93k | 23,98k | Automatic Disposition | 4,85 - 4,88 | 292,86k | -1,66% |
| 2026-04-06 | Mr. Abhimanyu VermaEVP & CTO | -3,55k | 17,26k | Automatic Disposition | 4,86 - 4,87 | 204,40k | -1,71% |
| 2026-04-06 | Dr. Zhenyu XuExec. VP & Chief Scientific Officer | -5,10k | 24,78k | Automatic Disposition | 4,85 - 4,87 | 644,95k | -0,78% |
| 2026-04-06 | Ms. Manuela Da Silva ValenteExec. VP & CPO | -4,97k | 24,15k | Automatic Disposition | 4,85 - 4,87 | 99,53k | -4,76% |
| 2026-03-31 | Mr. Kevin PuylaertSVP & Chief Sales Officer | -3,00 | 14,13 | Vente | 4,71 | 92,38k | -0,00% |
| 2026-03-19 | Dr. Philippe MenuExec. VP, Chief Medical Officer & Chief Product Officer | -608,00 | 2,91k | Automatic Disposition | 4,79 | 173,62k | -0,35% |
| 2026-03-19 | Dr. Jurgi CamblongCo-Founder, CEO & Director | -4,49k | 21,41k | Automatic Disposition | 4,77 | 3,30M | -0,14% |
| 2026-03-19 | Mr. Daan van WellExec. VP and Chief Legal & Compliance Officer | -684,00 | 3,27k | Automatic Disposition | 4,79 | 261,24k | -0,26% |
| 2026-03-19 | Mr. George A. CardozaExec. VP & CFO | -774,00 | 3,70k | Automatic Disposition | 4,79 | 184,86k | -0,42% |
| 2026-03-19 | Mr. Kevin PuylaertSVP & Chief Sales Officer | -33,00 | 157,08 | Vente | 4,76 | 92,39k | -0,04% |
| 2026-03-19 | Dr. Zhenyu XuExec. VP & Chief Scientific Officer | -608,00 | 2,91k | Automatic Disposition | 4,78 | 537,12k | -0,11% |
| 2026-03-19 | Ms. Manuela Da Silva ValenteExec. VP & CPO | -380,00 | 1,82k | Automatic Disposition | 4,79 | 84,95k | -0,45% |
| 2026-03-19 | Mr. Ross Jordan MukenPresident | -1,18k | 5,67k | Automatic Disposition | 4,79 | 308,02k | -0,38% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
